FDAnews
www.fdanews.com/articles/150566-par-pharmaceutical-receives-final-approval-to-market-tretinoin-capsules

Par Pharmaceutical Receives Final Approval to Market Tretinoin Capsules

October 29, 2012
Par Pharmaceutical announced that its operating subsidiary, Anchen Pharmaceuticals, has received final approval from the FDA for its ANDA for tretinoin capsules, 10 mg. 
The Sacramento Bee